Emerging computational technologies in human leishmaniasis: where are we?

Imagem de Miniatura
Arquivos
art_TUON_Emerging_computational_technologies_in_human_leishmaniasis_where_are_2022.PDF (469.65 KB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Autores
TUON, Felipe Francisco
ZEQUINAO, Tiago
CRUZ, June Alisson Westarb
Citação
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, v.116, n.11, p.981-985, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human leishmaniasis is a neglected tropical disease (NTD) with high morbidity and is endemic in low- to middle-income countries. Its diagnosis, treatment and epidemiological control methods are outdated and obsolete, which has become a challenge for health practitioners in controlling the disease. Computational methods have proven to be beneficial and have become popular in many fields of medicine, especially in affluent countries. However, they have not been widely used for NTDs. To date, few computational technologies have been employed for leishmaniasis. Although new technologies in leishmaniasis are theorized, they have only been minimally applied and have not been updated, even in other infections. Research and development on NTDs suffers from the inherent difficulties of the demographic regions the diseases afflict. In this narrative review we described the e-tools available in managing leishmaniasis, ranging from drug discovery to treatment.
Palavras-chave
artificial intelligence, heath technologies, leishmaniasis, neglected tropical diseases, telemedicine
URI
https://observatorio.fm.usp.br/handle/OPI/50545
Referências
  1. Castillo-Garit JA, 2018, CURR TOP MED CHEM, V18, P2347, DOI 10.2174/1568026619666181130121558
  2. Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
  3. Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003
  4. Amato VS, 2009, INT J DERMATOL, V48, P1091, DOI 10.1111/j.1365-4632.2009.04099.x
  5. Bamorovat M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250904
  6. Nunes BEBR, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0262-2019
  7. Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
  8. Bhunia GS, 2012, PATHOG GLOB HEALTH, V106, P150, DOI 10.1179/2047773212Y.0000000014
  9. Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2
  10. Carrion C, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/22478
  11. Devrim I, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1416-8
  12. Dorsey ER, 2020, LANCET, V395, P859, DOI 10.1016/S0140-6736(20)30424-4
  13. Duffy S, 2018, NEW ENGL J MED, V378, P104, DOI 10.1056/NEJMp1710735
  14. Gadzinski AJ, 2020, J UROLOGY, V204, P14, DOI 10.1097/JU.0000000000001033
  15. Gebreyohannes EA, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0491-7
  16. Goodchild MF, 2007, INT J SPAT DATA INFR, V2, P24
  17. Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216
  18. Heipke C, 2010, ISPRS J PHOTOGRAMM, V65, P550, DOI 10.1016/j.isprsjprs.2010.06.005
  19. Karimkhani C, 2017, LANCET INFECT DIS, V17, P264, DOI 10.1016/S1473-3099(16)30217-1
  20. Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7
  21. Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355
  22. Malone JB, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010015
  23. Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0
  24. Messagier AL, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00387
  25. Mollalo A, 2018, ACTA TROP, V188, P187, DOI 10.1016/j.actatropica.2018.09.004
  26. Ostad M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159546
  27. Sarmiento OJO, 2021, BMC RES NOTES, V14, DOI 10.1186/s13104-021-05618-4
  28. Parikh PJ, 2017, INT J MED INFORM, V108, P42, DOI 10.1016/j.ijmedinf.2017.09.005
  29. Peiffer-Smadja N, 2020, CLIN MICROBIOL INFEC, V26, P584, DOI 10.1016/j.cmi.2019.09.009
  30. Saran S, 2020, J INDIAN SOC REMOTE, V48, P1121, DOI 10.1007/s12524-020-01140-5
  31. Schroeder L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103718
  32. Sofizadeh A, 2018, J VECTOR DIS, V55, P297, DOI 10.4103/0972-9062.256565
  33. Sood S, 2007, TELEMED J E-HEALTH, V13, P573, DOI 10.1089/tmj.2006.0073
  34. Tilahun B, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00307-1
  35. Tuon FF, 2008, FEMS IMMUNOL MED MIC, V54, P158, DOI 10.1111/j.1574-695X.2008.00455.x
  36. Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x
  37. Tuon FF, 2007, CLIN INFECT DIS, V44, P1525, DOI 10.1086/517848
  38. Tuon FF, 2009, INT J DERMATOL, V48, P201, DOI 10.1111/j.1365-4632.2009.03982.x
  39. World Health Organization, 2011, MHEALTH NEW HORIZONS
  40. Zundel KM, 1996, B MED LIBR ASSOC, V84, P71

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - ODS/03